News

The US FDA has approved the Renuvion APR handheld device for the coagulation and contraction of soft tissues, including subcutaneous tissue. This breakthrough technology aims to improve sagging skin, particularly in the neck and chin areas. The device utilizes radiofrequency energy combined with helium plasma technology, offering a precise and effective treatment option. For more detailed information and other FDA updates, please read the full report.

Through the sharing of clinical surgical experiences by physicians, Renuvion has been proven to achieve effective skin tightening, significantly enhancing the results of tightening procedures.

Mary Fitzgerald, star of Netflix's "Selling Sunset," noticed sagging skin on her neck after turning 40 and decided to undergo Renuvion's minimally invasive scarless treatment. This FDA-approved technology is designed specifically to improve sagging skin in the neck and chin areas. Mary shared her treatment journey on Instagram, expressing her anticipation for a tighter neck. For more detailed information, please read the full report.

At the Aesthetic Society conference, several innovative technologies in the field of aesthetic surgery were showcased. Highlights include Renuvion neck treatment technology, new high-tech breast implants, minimally invasive skin tightening treatments, AI-assisted liposuction, vaginal microneedling treatments, and needle-free sweat control patches. These advancements have garnered significant attention from attending plastic surgeons, indicating new trends in the future of aesthetic surgery. For more information on these innovative technologies, please read the full report.